161 related articles for article (PubMed ID: 12091045)
1. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast: a venografic controlled study.
Jørgensen PS; Warming T; Hansen K; Paltved C; Vibeke Berg H; Jensen R; Kirchhoff-Jensen R; Kjaer L; Kerbouche N; Leth-Espensen P; Narvestad E; Rasmussen SW; Sloth C; Tørholm C; Wille-Jørgensen P
Thromb Res; 2002 Mar; 105(6):477-80. PubMed ID: 12091045
[TBL] [Abstract][Full Text] [Related]
2. Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.
Lassen MR; Borris LC; Jensen HP; Poulsen KA; Ejstrud P; Andersen BS
Clin Appl Thromb Hemost; 2000 Jan; 6(1):53-7. PubMed ID: 10726050
[TBL] [Abstract][Full Text] [Related]
3. [Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].
Kock HJ; Schmit-Neuerburg KP; Hanke J; Hakmann A; Althoff M; Rudofsky G; Hirche H
Chirurg; 1993 Jun; 64(6):483-91. PubMed ID: 8395380
[TBL] [Abstract][Full Text] [Related]
4. Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.
Hyers TM; Spyropoulos AC;
J Thromb Thrombolysis; 2007 Dec; 24(3):225-32. PubMed ID: 17334932
[TBL] [Abstract][Full Text] [Related]
5. Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days.
Siguret V; Pautas E; Février M; Wipff C; Durand-Gasselin B; Laurent M; Andreux JP; d'Urso M; Gaussem P
Thromb Haemost; 2000 Nov; 84(5):800-4. PubMed ID: 11127859
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.
Bara L; Planes A; Samama MM
Br J Haematol; 1999 Feb; 104(2):230-40. PubMed ID: 10050702
[TBL] [Abstract][Full Text] [Related]
7. Tinzaparin sodium: a review of its pharmacology and clinical use in the prophylaxis and treatment of thromboembolic disease.
Cheer SM; Dunn CJ; Foster R
Drugs; 2004; 64(13):1479-502. PubMed ID: 15212562
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast.
Spannagel U; Kujath P
Semin Thromb Hemost; 1993; 19 Suppl 1():131-41. PubMed ID: 8395716
[TBL] [Abstract][Full Text] [Related]
9. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg.
Kock HJ; Schmit-Neuerburg KP; Hanke J; Rudofsky G; Hirche H
Lancet; 1995 Aug; 346(8973):459-61. PubMed ID: 7637478
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
[TBL] [Abstract][Full Text] [Related]
11. Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during haemodialysis.
Hoy SM; Scott LJ; Plosker GL
Drugs; 2010 Jul; 70(10):1319-47. PubMed ID: 20568836
[TBL] [Abstract][Full Text] [Related]
12. Home treatment of deep vein thrombosis. An out-patient treatment model with once-daily injection of low-molecular-weight heparin (tinzaparin) in 555 patients.
Lapidus L; Börretzen J; Fahlén M; Thomsen HG; Hasselblom S; Larson L; Nordström H; Stigendal L; Waller L
Pathophysiol Haemost Thromb; 2002; 32(2):59-66. PubMed ID: 12214150
[TBL] [Abstract][Full Text] [Related]
13. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
14. [Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].
Kock HJ; Schmit-Neuerburg KP; Hanke J; Terwort A; Rudofsky G; Hirche H
Unfallchirurgie; 1994 Dec; 20(6):319-28. PubMed ID: 7871610
[TBL] [Abstract][Full Text] [Related]
15. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
Hull RD; Pineo GF; Brant R; Liang J; Cook R; Solymoss S; Poon MC; Raskob G;
Am J Med; 2009 Aug; 122(8):762-769.e3. PubMed ID: 19635277
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS).
Leizorovicz A; Siguret V; Mottier D; ; Leizorovicz A; Siguret V; Mottier D; Clonier F; Janas M; Stinson J; Townshend G; Maddalena M
Thromb Res; 2011 Jul; 128(1):27-34. PubMed ID: 21477846
[TBL] [Abstract][Full Text] [Related]
17. Should orthopedic outpatients with lower limb casts be given deep vein thrombosis prophylaxis?
Thomas S; Van Kampen M
Clin Appl Thromb Hemost; 2011 Aug; 17(4):405-7. PubMed ID: 20547549
[TBL] [Abstract][Full Text] [Related]
18. Tinzaparin sodium for thrombosis treatment and prevention during pregnancy.
Smith MP; Norris LA; Steer PJ; Savidge GF; Bonnar J
Am J Obstet Gynecol; 2004 Feb; 190(2):495-501. PubMed ID: 14981396
[TBL] [Abstract][Full Text] [Related]
19. Tinzaparin sodium: a low-molecular-weight heparin.
Neely JL; Carlson SS; Lenhart SE
Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial.
Daskalopoulos ME; Daskalopoulou SS; Tzortzis E; Sfiridis P; Nikolaou A; Dimitroulis D; Kakissis I; Liapis CD
Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):638-50. PubMed ID: 15878544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
